Y-MABS THERAPEUTICS INC's ticker is YMAB and the CUSIP is 984241109. A total of 97 filers reported holding Y-MABS THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $11,958,815 | -19.7% | 2,194,278 | 0.0% | 0.75% | -22.7% |
Q2 2023 | $14,899,148 | +35.5% | 2,194,278 | 0.0% | 0.98% | +38.8% |
Q1 2023 | $10,993,333 | +2.7% | 2,194,278 | 0.0% | 0.70% | +10.7% |
Q4 2022 | $10,708,077 | -66.2% | 2,194,278 | 0.0% | 0.64% | -65.5% |
Q3 2022 | $31,641,000 | -4.7% | 2,194,278 | 0.0% | 1.84% | -33.4% |
Q2 2022 | $33,199,000 | +27.4% | 2,194,278 | 0.0% | 2.76% | +39.8% |
Q1 2022 | $26,068,000 | -26.7% | 2,194,278 | 0.0% | 1.98% | -4.8% |
Q4 2021 | $35,569,000 | -43.2% | 2,194,278 | 0.0% | 2.08% | -44.0% |
Q3 2021 | $62,625,000 | -15.6% | 2,194,278 | 0.0% | 3.71% | -13.2% |
Q2 2021 | $74,167,000 | +11.8% | 2,194,278 | 0.0% | 4.28% | +7.2% |
Q1 2021 | $66,355,000 | -38.9% | 2,194,278 | 0.0% | 3.99% | -38.3% |
Q4 2020 | $108,639,000 | +29.0% | 2,194,278 | 0.0% | 6.47% | +3.5% |
Q3 2020 | $84,238,000 | -11.1% | 2,194,278 | 0.0% | 6.25% | +4.5% |
Q2 2020 | $94,793,000 | +65.5% | 2,194,278 | 0.0% | 5.98% | +12.8% |
Q1 2020 | $57,271,000 | -16.5% | 2,194,278 | 0.0% | 5.30% | +7.2% |
Q4 2019 | $68,571,000 | +25.0% | 2,194,278 | +4.3% | 4.94% | -0.3% |
Q3 2019 | $54,837,000 | +13.9% | 2,104,278 | 0.0% | 4.96% | +12.1% |
Q2 2019 | $48,125,000 | -12.7% | 2,104,278 | 0.0% | 4.42% | -16.8% |
Q1 2019 | $55,153,000 | +28.9% | 2,104,278 | 0.0% | 5.32% | -0.3% |
Q4 2018 | $42,801,000 | -23.4% | 2,104,278 | 0.0% | 5.33% | +7.0% |
Q3 2018 | $55,890,000 | – | 2,104,278 | – | 4.98% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Memorial Sloan Kettering Cancer Center | 216,916 | $6,191,000 | 3.86% |
Sofinnova Investments, Inc. | 2,194,278 | $62,625,000 | 3.71% |
MPM BioImpact LLC | 452,970 | $12,928,000 | 2.00% |
Soleus Capital Management, L.P. | 265,700 | $7,583,000 | 1.18% |
ASHFORD CAPITAL MANAGEMENT INC | 452,110 | $12,903,000 | 1.17% |
ORACLE INVESTMENT MANAGEMENT INC | 315,642 | $9,008,000 | 1.12% |
First Light Asset Management, LLC | 577,663 | $16,487,000 | 1.09% |
Lombard Odier Asset Management (Switzerland) SA | 352,839 | $10,070,000 | 0.62% |
Cormorant Asset Management, LP | 500,000 | $14,270,000 | 0.58% |
Artal Group S.A. | 400,000 | $11,416,000 | 0.26% |